Review of Clinical Neurology

Review of Clinical Neurology

Friday, March 24, 2023 - Sunday, March 26, 2023

9th Annual UCLA Review of Clinical Neurology

The UCLA Review of Clinical Neurology Virtual CME Course is designed to provide a comprehensive and practical review of core neurological disorders. It is intended for neurologists who wish to strengthen their competency and proficiency in evaluating, diagnosing, and managing a broad range of neurological disorders.

The course is organized to provide attendees with a review of clinical neurology based on major disease topics. Each neurological core topic will be organized to summarize the clinical spectrum of the disorders, pathophysiology, etiology, diagnostic techniques, and management options. Each lecture will discuss recent advancements made in the last year and their relevance to COVID-19.

Target Audience

This course is designed for practicing neurologists in private, health groups, or academic practice, as well as neurology, psychiatry, and neurosurgery trainees (residents, fellows). The course will also be very helpful for allied healthcare providers in neuroscience specialties (psychologists, physician assistants, nurses, and nurse practitioners, speech pathologists, and physical and occupational therapists.


Virtual meeting instructions in anticipation of the course will be provided to enrollees two weeks prior to the conference date.

Enrollees will be provided the opportunity to review recorded sessions up to 3 weeks following the conference.

Course Fees

Register by March 1, 2023 to take advantage of pre-registration rates.

  • $650 Physicians (pre-registration)
  • $750 Physicians (after March 1, 2023)
  • $350 Allied Health Professionals (pre-registration)
  • $500 Allied Health Professionals (after March 1, 2023)
  • $300 Trainees


Cancellations must be received March 13, 2023 by email to and will be subject to a $75 processing fee. No refunds will be given after that date. If, for any reason, the course must be canceled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.


If you have questions about enrollment, please call (310) 794-2620 or email


If you have questions about the exhibitor opportunities, please call (310) 794-2620 or email


At the conclusion of this course, participants should be able to:

  • Utilize most current evidenced-based practices to improve confidence in diagnosing and managing major disease states in neurology, including multiple sclerosis, headaches, epilepsy, central nervous system infections including COVID-19 infection, movement disorders, neurodegenerative disorders, sleep disorders, neuromuscular diseases, neuro-otology, stroke management, neuro-ophthalmology, ethical principles of disclosure of neurodegenerative conditions in neurology.
  • Discuss neurologic disease utilizing a case-based approach across the age groups from pediatrics to an older age.
  • Explore the utility of neurologic testing, including cerebrospinal fluid analysis, neuropsychiatric testing, neuroimaging, and neurophysiological assessments, including polysomnography, electroencephalography, electromyography, and nerve conduction velocity testing.
  • Discuss the underlying neuropathology of key neurological conditions and appraise the utility of disease-modifying treatments in representative conditions, including Alzheimer’s disease and multiple sclerosis.
  • Identify appropriate the most current appropriate and innovative therapeutic strategies for common neurologic disorders and complaints.
  • Apply the principles of ethics to the disclosure of conditions and testing that might predict the risk of future development of neurodegenerative conditions.


The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, designates this live activity for a maximum of 24.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Board of Psychiatry and Neurology has reviewed the 9th Annual UCLA Review of Clinical Neurology and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

The California State Board of Registered Nursing accepts courses approved for the AMA PRA Category 1 Credits™ as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.


The FDA has issued a concept paper that classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manage all identified potential conflicts of interest prior to the program. UCLA fully endorses the letter and spirit of these concepts.

Event Details